79 related articles for article (PubMed ID: 3259467)
21. Leukemia derived growth factors produced by human malignant T-lymphoid cell lines.
Uittenbogaart CH; Nishanian PG; Anisman DJ; Erikson TK; Fahey JL
Cancer Res; 1986 Mar; 46(3):1219-23. PubMed ID: 3080240
[TBL] [Abstract][Full Text] [Related]
22. Interleukin 10 protects activated human T lymphocytes against growth factor withdrawal-induced cell death but only anti-fas antibody can prevent activation-induced cell death.
Pawelec G; Hambrecht A; Rehbein A; Adibzadeh M
Cytokine; 1996 Dec; 8(12):877-81. PubMed ID: 9050744
[TBL] [Abstract][Full Text] [Related]
23. Effect of transforming growth factor-beta on early and late activation events in human T cells.
Ahuja SS; Paliogianni F; Yamada H; Balow JE; Boumpas DT
J Immunol; 1993 Apr; 150(8 Pt 1):3109-18. PubMed ID: 8468460
[TBL] [Abstract][Full Text] [Related]
24. Biology and biochemistry of T cell-derived lymphokines. I. The coordinate synthesis of interleukin 2 and colony-stimulating factors in a murine T cell lymphoma.
Watson JD
J Immunol; 1983 Jul; 131(1):293-7. PubMed ID: 6602832
[TBL] [Abstract][Full Text] [Related]
25. Concanavalin A-induced human lymphocyte mitogenic factor: activity distinct from interleukin 1 and 2.
Duncan MR; George FW; Hadden JW
J Immunol; 1982 Jul; 129(1):56-62. PubMed ID: 6806367
[TBL] [Abstract][Full Text] [Related]
26. Growth factor-independent proliferation of rat mammary carcinoma cells by autocrine secretion of neu-differentiation factor/heregulin and transforming growth factor-alpha.
Ethier SP; Langton BC; Dilts CA
Mol Carcinog; 1996 Feb; 15(2):134-43. PubMed ID: 8599580
[TBL] [Abstract][Full Text] [Related]
27. Lung-derived growth factor that stimulates the growth of lung-metastasizing tumor cells: identification as transferrin.
Cavanaugh PG; Nicolson GL
J Cell Biochem; 1991 Nov; 47(3):261-71. PubMed ID: 1791188
[TBL] [Abstract][Full Text] [Related]
28. A mitogenic factor, released by stimulated human mononuclear cells and distinct from interleukin 2 (IL 2), B cell growth factor (BCGF), and interleukin 1 (IL 1).
Kasakura S; Taguchi M; Watanabe Y; Okubo T; Murachi T; Uchino H; Hanaoka M
J Immunol; 1984 Dec; 133(6):3084-90. PubMed ID: 6238094
[TBL] [Abstract][Full Text] [Related]
29. Effects of platelet-derived growth factor and epidermal growth factor on antigen-induced proliferation of human T-cell lines.
Acres RB; Lamb JR; Feldman M
Immunology; 1985 Jan; 54(1):9-16. PubMed ID: 3871731
[TBL] [Abstract][Full Text] [Related]
30. The same cloned murine B lymphoma cell lines can be selectively induced to release either interleukin-1- or interleukin-2-like factor activity.
Walker EB; Leemhuis T
Lymphokine Res; 1987; 6(2):71-81. PubMed ID: 3495708
[TBL] [Abstract][Full Text] [Related]
31. A murine stromal cell line promotes the proliferation of the human factor-dependent leukemic cell line UT-7.
Auffray I; Dubart A; Izac B; Vainchenker W; Coulombel L
Exp Hematol; 1994 May; 22(5):417-24. PubMed ID: 7513651
[TBL] [Abstract][Full Text] [Related]
32. Biological and karyotypic characterization of a new cell line derived from human gliosarcoma.
Westphal M; Haensel M; Mueller D; Laas R; Kunzmann R; Rohde E; Koenig A; Hoelzel F; Herrmann HD
Cancer Res; 1988 Feb; 48(3):731-40. PubMed ID: 3275500
[TBL] [Abstract][Full Text] [Related]
33. T cell activation: differences in the signals required for IL 2 production by nonactivated and activated T cells.
Manger B; Weiss A; Weyand C; Goronzy J; Stobo JD
J Immunol; 1985 Dec; 135(6):3669-73. PubMed ID: 3934263
[TBL] [Abstract][Full Text] [Related]
34. Characterization of a keratinocyte-derived T cell growth factor distinct from interleukin 2 and B cell stimulatory factor 1.
Coleman DL; Kupper TS; Flood PM; Fultz CC; Horowitz MC
J Immunol; 1987 May; 138(10):3314-8. PubMed ID: 3494765
[TBL] [Abstract][Full Text] [Related]
35. The Chinese herbal remedy, T2, inhibits mitogen-induced cytokine gene transcription by T cells, but not initial signal transduction.
Tao X; Davis LS; Hashimoto K; Lipsky PE
J Pharmacol Exp Ther; 1996 Jan; 276(1):316-25. PubMed ID: 8558449
[TBL] [Abstract][Full Text] [Related]
36. Major histocompatibility complex-unrestricted cytolytic activity of human T cells. Analysis of precursor frequency and effector phenotype.
Patel SS; Thiele DL; Lipsky PE
J Immunol; 1987 Dec; 139(11):3886-95. PubMed ID: 3500232
[TBL] [Abstract][Full Text] [Related]
37. Induction of inhibitory activity for B cell differentiation in human CD8 T cells with pokeweed mitogen, dimaprit, and cAMP upregulating agents: countersuppressive effect of platelet factor 4.
Crisi GM; Katz IR; Zucker MB; Thorbecke GJ
Cell Immunol; 1996 Sep; 172(2):205-16. PubMed ID: 8964082
[TBL] [Abstract][Full Text] [Related]
38. Modulation of cell surface iron transferrin receptors by cellular density and state of activation.
Larrick JW; Cresswell P
J Supramol Struct; 1979; 11(4):579-86. PubMed ID: 232525
[TBL] [Abstract][Full Text] [Related]
39. Signals required for activation and growth of autoimmune T lymphocytes.
Santoro TJ; Malek TR; Rosenberg YJ; Morse HC; Steinberg AD
J Mol Cell Immunol; 1984; 1(6):347-56. PubMed ID: 6086044
[TBL] [Abstract][Full Text] [Related]
40. Ex vivo expansion of megakaryocyte progenitors: effect of various growth factor combinations on CD34+ progenitor cells from bone marrow and G-CSF-mobilized peripheral blood.
Gehling UM; Ryder JW; Hogan CJ; Hami L; McNiece I; Franklin W; Williams S; Helm K; King J; Shpall EJ
Exp Hematol; 1997 Oct; 25(11):1125-39. PubMed ID: 9328449
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
